Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Overview[ - collapse ][ - ]
Purpose | This study will investigate the efficacy and safety of two doses (high and low) of empagliflozin in combination with metformin (500 mg and 1000 mg) administered twice daily in patients with type 2 diabetes mellitus (T2DM). Study will compare four dose combinations of empagliflozin + metformin versus each individual component after 24 weeks of treatment. |
---|---|
Condition | Diabetes Mellitus, Type 2 Hyperglycemia |
Intervention | Drug: Empagliflozin low dose qd Drug: Metformin 500 mg bid Drug: Metformin 1000 mg bid Drug: Empagliflozin high dose qd Drug: Empagliflozin low dose bid Drug: Metformin 500 mg bid Drug: Empagliflozin high dose bid Drug: Empagliflozin low dose bid Drug: Metformin 1000 mg bid Drug: Metformin 500 mg bid Drug: Metformin 1000 mg bid Drug: Empagliflozin high dose bid Drug: Metformin 1000 mg bid Drug: Empagliflozin high dose bid |
Phase | Phase 3 |
Sponsor | Boehringer Ingelheim |
Responsible Party | Boehringer Ingelheim |
ClinicalTrials.gov Identifier | NCT01719003 |
First Received | October 30, 2012 |
Last Updated | April 16, 2014 |
Last verified | April 2014 |
Tracking Information[ + expand ][ + ]
First Received Date | October 30, 2012 |
---|---|
Last Updated Date | April 16, 2014 |
Start Date | October 2012 |
Estimated Primary Completion Date | November 2014 |
Current Primary Outcome Measures | Change from baseline in HbA1c [Time Frame: 24 weeks] [Designated as safety issue: No] |
Current Secondary Outcome Measures |
|
Descriptive Information[ + expand ][ + ]
Brief Title | Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes |
---|---|
Official Title | A 24-week Phase III Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Twice Daily Oral Administration of Empagliflozin + Metformin Compared With the Individual Components of Empagliflozin or Metformin in Drug Naive Patients With Type 2 Diabetes Mellitus |
Brief Summary | This study will investigate the efficacy and safety of two doses (high and low) of empagliflozin in combination with metformin (500 mg and 1000 mg) administered twice daily in patients with type 2 diabetes mellitus (T2DM). Study will compare four dose combinations of empagliflozin + metformin versus each individual component after 24 weeks of treatment. |
Detailed Description | Not Provided |
Study Type | Interventional |
Study Phase | Phase 3 |
Study Design | Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment |
Condition |
|
Intervention | Drug: Empagliflozin low dose qd Empagliflozin low dose once daily Drug: Metformin 500 mg bid Metformin 500 mg twice daily Drug: Metformin 1000 mg bid Metformin 1000 mg twice daily Drug: Empagliflozin high dose qd Empagliflozin high dose once daily Drug: Empagliflozin low dose bid Empagliflozin low dose split twice daily Drug: Metformin 500 mg bid Metformin 500 mg twice daily Drug: Empagliflozin high dose bid Empagliflozin high dose split twice daily Drug: Empagliflozin low dose bid Empagliflozin low dose split twice daily Drug: Metformin 1000 mg bid Metformin 1000 mg twice daily Drug: Metformin 500 mg bid Metformin 500 mg twice daily Drug: Metformin 1000 mg bid Metformin 1000 mg twice daily Drug: Empagliflozin high dose bid Empagliflozin high dose split twice daily Drug: Metformin 1000 mg bid Metformin 1000 mg twice daily Drug: Empagliflozin high dose bid Empagliflozin high dose split twice daily |
Study Arm (s) |
|
Recruitment Information[ + expand ][ + ]
Recruitment Status | Recruiting |
---|---|
Estimated Enrollment | 1397 |
Estimated Completion Date | November 2014 |
Estimated Primary Completion Date | November 2014 |
Eligibility Criteria | Inclusion criteria: 1. Diagnosis of type 2 diabetes mellitus prior to informed consent 2. Male and female patients on diet and exercise regimen who are drug-naive, defined as absence of any oral antidiabetic therapy for 12 weeks prior to randomization 3. HbA1c >=7.5% and <= 12% (>=58.5 mmol/mol and <=107.7 mmol/mol) 4. Body Mass Index (BMI) <= 45 kg/m2 at screening Exclusion criteria: 1. Uncontrolled hyperglycemia with a glucose level >240 mg/dl (>13.3 mmol/L) after an overnight fast during placebo run-in and confirmed by a second laboratory measurement (not on the same day) 2. Any antidiabetic drug within 12 weeks prior to randomization 3. Impaired renal function, defined as estimated creatinine clearance rate (eCCr) <60 ml/min (Cockcroft-Gault formula) as determined during screening and/or run-in period 4. Contraindications to metformin according to the local label |
Gender | Both |
Ages | 18 Years |
Accepts Healthy Volunteers | No |
Contacts | Contact: Boehringer Ingelheim Call Center 1-800-243-0127 clintriage.rdg@boehringer-ingelheim.com |
Location Countries | United States, Brazil, Canada, Czech Republic, Egypt, France, Germany, Guatemala, Korea, Republic of, Lebanon, Malaysia, Mexico, Peru, Philippines, Russian Federation, Serbia, Spain, Taiwan, Thailand, Turkey, United Kingdom |
Administrative Information[ + expand ][ + ]
NCT Number | NCT01719003 |
---|---|
Other Study ID Numbers | 1276.1 |
Has Data Monitoring Committee | Not Provided |
Information Provided By | Boehringer Ingelheim |
Study Sponsor | Boehringer Ingelheim |
Collaborators | Eli Lilly and Company |
Investigators | Study Chair: Boehringer Ingelheim Boehringer Ingelheim |
Verification Date | April 2014 |
Locations[ + expand ][ + ]
1276.1.10014 Boehringer Ingelheim Investigational Site | Birmingham, Alabama, United States Recruiting |
---|---|
1276.1.10019 Boehringer Ingelheim Investigational Site | Birmingham, Alabama, United States Recruiting |
1276.1.10044 Boehringer Ingelheim Investigational Site | Hot Springs, Alaska, United States Recruiting |
1276.1.10010 Boehringer Ingelheim Investigational Site | Glendale, Arizona, United States Recruiting |
1276.1.10035 Boehringer Ingelheim Investigational Site | Searcy, Arkansas, United States Recruiting |
1276.1.10046 Boehringer Ingelheim Investigational Site | Chula Vista, California, United States Recruiting |
1276.1.10006 Boehringer Ingelheim Investigational Site | Huntington Beach, California, United States Recruiting |
1276.1.10043 Boehringer Ingelheim Investigational Site | La Mesa, California, United States Recruiting |
1276.1.10040 Boehringer Ingelheim Investigational Site | Los Angeles, California, United States Recruiting |
1276.1.10009 Boehringer Ingelheim Investigational Site | Los Angeles, California, United States Recruiting |
1276.1.10045 Boehringer Ingelheim Investigational Site | Oceanside, California, United States Recruiting |
1276.1.10042 Boehringer Ingelheim Investigational Site | Colorado Springs, Colorado, United States Recruiting |
1276.1.10001 Boehringer Ingelheim Investigational Site | Denver, Colorado, United States Recruiting |
1276.1.10003 Boehringer Ingelheim Investigational Site | Northglenn, Colorado, United States Recruiting |
1276.1.10039 Boehringer Ingelheim Investigational Site | Fort Lauderdale, Florida, United States Recruiting |
1276.1.10026 Boehringer Ingelheim Investigational Site | Fort Lauderdale, Florida, United States Recruiting |
1276.1.10024 Boehringer Ingelheim Investigational Site | Oldsmar, Florida, United States Recruiting |
1276.1.10027 Boehringer Ingelheim Investigational Site | Port Orange, Florida, United States Recruiting |
1276.1.10023 Boehringer Ingelheim Investigational Site | Marietta, Georgia, United States Recruiting |
1276.1.10034 Boehringer Ingelheim Investigational Site | Evansville, Indiana, United States Recruiting |
1276.1.10032 Boehringer Ingelheim Investigational Site | Fall River, Massachusetts, United States Recruiting |
1276.1.10036 Boehringer Ingelheim Investigational Site | Bridgman, Michigan, United States Recruiting |
1276.1.10037 Boehringer Ingelheim Investigational Site | Hazelwood, Missouri, United States Recruiting |
1276.1.10007 Boehringer Ingelheim Investigational Site | Las Vegas, Nevada, United States Recruiting |
1276.1.10015 Boehringer Ingelheim Investigational Site | Union, New Jersey, United States Recruiting |
1276.1.10033 Boehringer Ingelheim Investigational Site | Asheboro, North Carolina, United States Recruiting |
1276.1.10022 Boehringer Ingelheim Investigational Site | Burlington, North Carolina, United States Recruiting |
1276.1.10002 Boehringer Ingelheim Investigational Site | Lenoir, North Carolina, United States Recruiting |
1276.1.10005 Boehringer Ingelheim Investigational Site | Cincinnati, Ohio, United States Recruiting |
1276.1.10011 Boehringer Ingelheim Investigational Site | Gallipolis, Ohio, United States Recruiting |
1276.1.10030 Boehringer Ingelheim Investigational Site | Columbia, South Carolina, United States Recruiting |
1276.1.10008 Boehringer Ingelheim Investigational Site | Greer, South Carolina, United States Recruiting |
1276.1.10013 Boehringer Ingelheim Investigational Site | Hodges, South Carolina, United States Recruiting |
1276.1.10017 Boehringer Ingelheim Investigational Site | Humboldt, Tennessee, United States Recruiting |
1276.1.10018 Boehringer Ingelheim Investigational Site | Houston, Texas, United States Recruiting |
1276.1.10025 Boehringer Ingelheim Investigational Site | Houston, Texas, United States Recruiting |
1276.1.10028 Boehringer Ingelheim Investigational Site | Houston, Texas, United States Recruiting |
1276.1.10016 Boehringer Ingelheim Investigational Site | Kingwood, Texas, United States Completed |
1276.1.10021 Boehringer Ingelheim Investigational Site | San Antonio, Texas, United States Recruiting |
1276.1.10041 Boehringer Ingelheim Investigational Site | San Antonio, Texas, United States Recruiting |
1276.1.10004 Boehringer Ingelheim Investigational Site | Manassas, Virginia, United States Recruiting |
1276.1.10012 Boehringer Ingelheim Investigational Site | Wenatchee, Washington, United States Recruiting |
1276.1.55008 Boehringer Ingelheim Investigational Site | Belém, Brazil Recruiting |
1276.1.55003 Boehringer Ingelheim Investigational Site | Brasilia, Brazil Recruiting |
1276.1.55007 Boehringer Ingelheim Investigational Site | Fortaleza, Brazil Recruiting |
1276.1.55006 Boehringer Ingelheim Investigational Site | Fortaleza, Brazil Recruiting |
1276.1.55009 Boehringer Ingelheim Investigational Site | Fortaleza, Brazil Recruiting |
1276.1.55004 Boehringer Ingelheim Investigational Site | Goiania, Brazil Recruiting |
1276.1.55002 Boehringer Ingelheim Investigational Site | Porto Alegre, Brazil Recruiting |
1276.1.55001 Boehringer Ingelheim Investigational Site | Sao Paulo, Brazil Recruiting |
1276.1.20003 Boehringer Ingelheim Investigational Site | Coquitlam, British Columbia, Canada Recruiting |
1276.1.20012 Boehringer Ingelheim Investigational Site | Coquitlam, British Columbia, Canada Recruiting |
1276.1.20008 Boehringer Ingelheim Investigational Site | Victoria, British Columbia, Canada Recruiting |
1276.1.20004 Boehringer Ingelheim Investigational Site | Antigonish, Nova Scotia, Canada Recruiting |
1276.1.20005 Boehringer Ingelheim Investigational Site | Hawkesbury, Ontario, Canada Recruiting |
1276.1.20013 Boehringer Ingelheim Investigational Site | Sarnia, Ontario, Canada Recruiting |
1276.1.20011 Boehringer Ingelheim Investigational Site | Stayner, Ontario, Canada Recruiting |
1276.1.20010 Boehringer Ingelheim Investigational Site | Strathroy, Ontario, Canada Recruiting |
1276.1.20006 Boehringer Ingelheim Investigational Site | Thornhill, Ontario, Canada Recruiting |
1276.1.20009 Boehringer Ingelheim Investigational Site | Toronto, Ontario, Canada Recruiting |
1276.1.20007 Boehringer Ingelheim Investigational Site | Mirabel, Quebec, Canada Recruiting |
1276.1.20001 Boehringer Ingelheim Investigational Site | Saskatoon, Saskatchewan, Canada Recruiting |
1276.1.20002 Boehringer Ingelheim Investigational Site | Quebec, Canada Recruiting |
1276.1.42002 Boehringer Ingelheim Investigational Site | Benatky nad Jizerou, Czech Republic Recruiting |
1276.1.42008 Boehringer Ingelheim Investigational Site | Olomouc, Czech Republic Recruiting |
1276.1.42007 Boehringer Ingelheim Investigational Site | Ostrava, Czech Republic Recruiting |
1276.1.42009 Boehringer Ingelheim Investigational Site | Plzen, Czech Republic Recruiting |
1276.1.42010 Boehringer Ingelheim Investigational Site | Praha 1, Czech Republic Recruiting |
1276.1.42004 Boehringer Ingelheim Investigational Site | Praha 10, Czech Republic Recruiting |
1276.1.42003 Boehringer Ingelheim Investigational Site | Praha 3, Czech Republic Recruiting |
1276.1.95001 Boehringer Ingelheim Investigational Site | Abbasia Cairo, Egypt, Egypt Recruiting |
1276.1.95003 Boehringer Ingelheim Investigational Site | Al Manial, Cairo, Egypt, Egypt Recruiting |
1276.1.95004 Boehringer Ingelheim Investigational Site | Alexandria, Egypt Recruiting |
1276.1.95005 Boehringer Ingelheim Investigational Site | Alexandria, Egypt Recruiting |
1276.1.95002 Boehringer Ingelheim Investigational Site | El Darasa Cairo Egypt, Egypt Recruiting |
1276.1.33004 Boehringer Ingelheim Investigational Site | Behren Les Forbach, France Completed |
1276.1.33012 Boehringer Ingelheim Investigational Site | Bersée, France Recruiting |
1276.1.33005 Boehringer Ingelheim Investigational Site | Cournonterral, France Recruiting |
1276.1.33007 Boehringer Ingelheim Investigational Site | Hautmont, France Completed |
1276.1.33013 Boehringer Ingelheim Investigational Site | Paris, France Recruiting |
1276.1.33001 Boehringer Ingelheim Investigational Site | Poitiers, France Recruiting |
1276.1.33003 Boehringer Ingelheim Investigational Site | Savonnières, France Recruiting |
1276.1.33006 Boehringer Ingelheim Investigational Site | St Genis des Fontaines, France Recruiting |
1276.1.33002 Boehringer Ingelheim Investigational Site | Thouars, France Recruiting |
1276.1.33011 Boehringer Ingelheim Investigational Site | Thun St amand, France Recruiting |
1276.1.33010 Boehringer Ingelheim Investigational Site | Tours, France Recruiting |
1276.1.33009 Boehringer Ingelheim Investigational Site | Vandome, France Recruiting |
1276.1.33008 Boehringer Ingelheim Investigational Site | Vieux Condé, France Recruiting |
1276.1.49005 Boehringer Ingelheim Investigational Site | Berlin, Germany Recruiting |
1276.1.49008 Boehringer Ingelheim Investigational Site | Celle, Germany Recruiting |
1276.1.49006 Boehringer Ingelheim Investigational Site | Dortmund, Germany Recruiting |
1276.1.49011 Boehringer Ingelheim Investigational Site | Dresden, Germany Recruiting |
1276.1.49003 Boehringer Ingelheim Investigational Site | Essen, Germany Recruiting |
1276.1.49007 Boehringer Ingelheim Investigational Site | Ingelheim, Germany Terminated |
1276.1.49014 Boehringer Ingelheim Investigational Site | Neuwied, Germany Recruiting |
1276.1.49004 Boehringer Ingelheim Investigational Site | Offenbach, Germany Recruiting |
1276.1.49002 Boehringer Ingelheim Investigational Site | Stuhr-Brinkum, Germany Recruiting |
1276.1.49012 Boehringer Ingelheim Investigational Site | Teuchern, Germany Recruiting |
1276.1.50002 Boehringer Ingelheim Investigational Site | Barbena Santa Rosa, Guatemala Recruiting |
1276.1.50003 Boehringer Ingelheim Investigational Site | Guatemala, Guatemala Recruiting |
1276.1.50005 Boehringer Ingelheim Investigational Site | Guatemala, Guatemala Recruiting |
1276.1.50006 Boehringer Ingelheim Investigational Site | Guatemala, Guatemala Recruiting |
1276.1.50001 Boehringer Ingelheim Investigational Site | Quetzaltenango, Guatemala Recruiting |
1276.1.82009 Boehringer Ingelheim Investigational Site | Busan, Korea, Republic of Recruiting |
1276.1.82006 Boehringer Ingelheim Investigational Site | Deagu, Korea, Republic of Recruiting |
1276.1.82010 Boehringer Ingelheim Investigational Site | Goyang, Korea, Republic of Recruiting |
1276.1.82001 Boehringer Ingelheim Investigational Site | Incheon, Korea, Republic of Recruiting |
1276.1.82005 Boehringer Ingelheim Investigational Site | Seoul, Korea, Republic of Recruiting |
1276.1.82008 Boehringer Ingelheim Investigational Site | Seoul, Korea, Republic of Recruiting |
1276.1.82004 Boehringer Ingelheim Investigational Site | Seoul, Korea, Republic of Recruiting |
1276.1.82002 Boehringer Ingelheim Investigational Site | Seoul, Korea, Republic of Recruiting |
1276.1.82007 Boehringer Ingelheim Investigational Site | Seoul, Korea, Republic of Recruiting |
1276.1.82003 Boehringer Ingelheim Investigational Site | Wonju, Korea, Republic of Recruiting |
1276.1.96001 Boehringer Ingelheim Investigational Site | Beirut, Lebanon Recruiting |
1276.1.96002 Boehringer Ingelheim Investigational Site | Chouf, Lebanon Recruiting |
1276.1.96003 Boehringer Ingelheim Investigational Site | Sidon, Lebanon Recruiting |
1276.1.96004 Boehringer Ingelheim Investigational Site | Sidon, Lebanon Recruiting |
1276.1.60002 Boehringer Ingelheim Investigational Site | Ipoh, Perak, Malaysia Recruiting |
1276.1.60001 Boehringer Ingelheim Investigational Site | Johor Bahru, Malaysia Recruiting |
1276.1.60003 Boehringer Ingelheim Investigational Site | Kubang Kerian, Malaysia Recruiting |
1276.1.52004 Boehringer Ingelheim Investigational Site | Aguascalientes, Mexico Recruiting |
1276.1.52007 Boehringer Ingelheim Investigational Site | Aguascalientes, Mexico Recruiting |
1276.1.52002 Boehringer Ingelheim Investigational Site | Ciudad de Mexico, Mexico Recruiting |
1276.1.52003 Boehringer Ingelheim Investigational Site | Guadalajara, Mexico Recruiting |
1276.1.52001 Boehringer Ingelheim Investigational Site | Monterrey, Mexico Recruiting |
1276.1.52006 Boehringer Ingelheim Investigational Site | San Lucas tepetlcalco, Mexico Recruiting |
1276.1.52005 Boehringer Ingelheim Investigational Site | Zapopan, Mexico Recruiting |
1276.1.51001 Boehringer Ingelheim Investigational Site | Lima, Peru Recruiting |
1276.1.51002 Boehringer Ingelheim Investigational Site | Lima, Peru Recruiting |
1276.1.51003 Boehringer Ingelheim Investigational Site | Lima, Peru Recruiting |
1276.1.51004 Boehringer Ingelheim Investigational Site | Lima, Peru Recruiting |
1276.1.51005 Boehringer Ingelheim Investigational Site | Lima, Peru Recruiting |
1276.1.63009 Boehringer Ingelheim Investigational Site | Cebu City, Cebu, Philippines Recruiting |
1276.1.63002 Boehringer Ingelheim Investigational Site | Cebu City, Philippines, Philippines Recruiting |
1276.1.63004 Boehringer Ingelheim Investigational Site | Davao City, Philippines Recruiting |
1276.1.63003 Boehringer Ingelheim Investigational Site | Iloilo City, Philippines Recruiting |
1276.1.63006 Boehringer Ingelheim Investigational Site | Manila, Philippines Recruiting |
1276.1.63001 Boehringer Ingelheim Investigational Site | Marikina City, Philippines Recruiting |
1276.1.63005 Boehringer Ingelheim Investigational Site | Maybunga, Pasig City, Philippines Recruiting |
1276.1.63007 Boehringer Ingelheim Investigational Site | San Juan City, Philippines Recruiting |
1276.1.63008 Boehringer Ingelheim Investigational Site | Tarlac, Philippines Recruiting |
1276.1.70012 Boehringer Ingelheim Investigational Site | Barnaul, Russian Federation Recruiting |
1276.1.70011 Boehringer Ingelheim Investigational Site | Kemerovo, Russian Federation Recruiting |
1276.1.70018 Boehringer Ingelheim Investigational Site | Novosibirsk, Russian Federation Recruiting |
1276.1.70015 Boehringer Ingelheim Investigational Site | Novosibirsk, Russian Federation Recruiting |
1276.1.70016 Boehringer Ingelheim Investigational Site | Novosibirsk, Russian Federation Recruiting |
1276.1.70007 Boehringer Ingelheim Investigational Site | Petrozavodsk, Russian Federation Recruiting |
1276.1.70009 Boehringer Ingelheim Investigational Site | Saratov, Russian Federation Recruiting |
1276.1.70010 Boehringer Ingelheim Investigational Site | Smolensk, Russian Federation Recruiting |
1276.1.70006 Boehringer Ingelheim Investigational Site | St. Petersburg, Russian Federation Recruiting |
1276.1.70005 Boehringer Ingelheim Investigational Site | St. Petersburg, Russian Federation Recruiting |
1276.1.70017 Boehringer Ingelheim Investigational Site | St. Petersburg, Russian Federation Recruiting |
1276.1.70013 Boehringer Ingelheim Investigational Site | Yaroslavl, Russian Federation Recruiting |
1276.1.38105 Boehringer Ingelheim Investigational Site | Belgrade, Serbia Recruiting |
1276.1.38107 Boehringer Ingelheim Investigational Site | Belgrade, Serbia Recruiting |
1276.1.38106 Boehringer Ingelheim Investigational Site | Belgrade, Serbia Recruiting |
1276.1.38104 Boehringer Ingelheim Investigational Site | Belgrade, Serbia Recruiting |
1276.1.38103 Boehringer Ingelheim Investigational Site | Kragujevac, Serbia Recruiting |
1276.1.38101 Boehringer Ingelheim Investigational Site | Nis, Serbia Recruiting |
1276.1.38108 Boehringer Ingelheim Investigational Site | Novi Sad, Serbia Recruiting |
1276.1.38102 Boehringer Ingelheim Investigational Site | Zajecar, Serbia Recruiting |
1276.1.34048 Boehringer Ingelheim Investigational Site | Alicante, Spain Recruiting |
1276.1.34050 Boehringer Ingelheim Investigational Site | Alzira, Spain Recruiting |
1276.1.34028 Boehringer Ingelheim Investigational Site | Madrid, Spain Recruiting |
1276.1.34045 Boehringer Ingelheim Investigational Site | pozuelo de Alarcon, Spain Recruiting |
1276.1.34034 Boehringer Ingelheim Investigational Site | Sabadell (Barcelona), Spain Recruiting |
1276.1.34027 Boehringer Ingelheim Investigational Site | Salamanca, Spain Recruiting |
1276.1.34052 Boehringer Ingelheim Investigational Site | Tarragona, Spain Recruiting |
1276.1.34051 Boehringer Ingelheim Investigational Site | Zaragoza, Spain Recruiting |
1276.1.88005 Boehringer Ingelheim Investigational Site | Kaohsiung City,, Taiwan Recruiting |
1276.1.88002 Boehringer Ingelheim Investigational Site | New Taipei City, Taiwan Recruiting |
1276.1.88004 Boehringer Ingelheim Investigational Site | Taichung, Taiwan Recruiting |
1276.1.88001 Boehringer Ingelheim Investigational Site | Taichung, Taiwan Recruiting |
1276.1.88003 Boehringer Ingelheim Investigational Site | Taichung, Taiwan Recruiting |
1276.1.88006 Boehringer Ingelheim Investigational Site | Taipei, Taiwan Recruiting |
1276.1.66001 Boehringer Ingelheim Investigational Site | Bangkok, Thailand, Thailand Recruiting |
1276.1.66003 Boehringer Ingelheim Investigational Site | Bangkok, Thailand, Thailand Recruiting |
1276.1.66002 Boehringer Ingelheim Investigational Site | Nakhon Ratchasima, Thailand Recruiting |
1276.1.90003 Boehringer Ingelheim Investigational Site | Ankara, Turkey Recruiting |
1276.1.90004 Boehringer Ingelheim Investigational Site | Antalya, Turkey Recruiting |
1276.1.90006 Boehringer Ingelheim Investigational Site | Denizli, Turkey Recruiting |
1276.1.90002 Boehringer Ingelheim Investigational Site | Erzurum, Turkey Recruiting |
1276.1.90005 Boehringer Ingelheim Investigational Site | Istanbul, Turkey Recruiting |
1276.1.90001 Boehringer Ingelheim Investigational Site | Izmir, Turkey Recruiting |
1276.1.44002 Boehringer Ingelheim Investigational Site | Bolton, United Kingdom Recruiting |
1276.1.44001 Boehringer Ingelheim Investigational Site | Bradford on Avon, United Kingdom Recruiting |
1276.1.44005 Boehringer Ingelheim Investigational Site | Chippenham, United Kingdom Recruiting |
1276.1.44006 Boehringer Ingelheim Investigational Site | Dagenham, United Kingdom Recruiting |
1276.1.44004 Boehringer Ingelheim Investigational Site | Doncaster, United Kingdom Recruiting |
1276.1.44008 Boehringer Ingelheim Investigational Site | Glasgow, United Kingdom Recruiting |
1276.1.44003 Boehringer Ingelheim Investigational Site | Leeds, United Kingdom Recruiting |
1276.1.44007 Boehringer Ingelheim Investigational Site | Manchester, United Kingdom Recruiting |
1276.1.44011 Boehringer Ingelheim Investigational Site | Mortimer, United Kingdom Recruiting |
1276.1.44009 Boehringer Ingelheim Investigational Site | Sandbach, United Kingdom Recruiting |